Notice of Effectiveness (effect)
March 28 2016 - 6:01AM
Edgar (US Regulatory)
|
UNITED STATES
|
|
SECURITIES AND EXCHANGE COMMISSION
|
|
Washington, D.C. 20549
|
NOTICE OF EFFECTIVENESS
|
|
|
|
Effective Date:
|
March 25,
2016
|
|
Form:
|
S-3
|
|
CIK:
|
0001479290
|
|
Company Name:
|
Revance Therapeutics, Inc.
|
|
File Number:
|
333-210001
|
Revance Therapeutics (NASDAQ:RVNC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Revance Therapeutics (NASDAQ:RVNC)
Historical Stock Chart
From Apr 2023 to Apr 2024
